Park Ha Biological Technology, a skincare and cosmetic products company based in Wuxi, China, has filed with the SEC to raise up to $7 million in an initial public offering. The company plans to offer 1.2 million shares at a price range of $5 to $7, aiming for a market value of $157 million. Park Ha operates through owned stores and franchisees in China, offering a wide range of skincare products for various skin issues. Founded in 2016, the company generated $2 million in revenue for the 12 months ending April 30, 2024. Park Ha plans to list on the Nasdaq under the symbol PHH, with Dawson James and EF Hutton serving as joint bookrunners on the deal. The company focuses on providing solutions for problematic skin with nearly 200 items across 18 series, covering areas such as skin protection, exfoliation, sebum film repair, microecological balance, and anti-aging. The IPO filing was made confidentially on December 29, 2023, showcasing the company’s potential for growth and expansion in the skincare and cosmetic market in China.
Source
Photo credit www.renaissancecapital.com
Park Ha Biological Technology, a Chinese skincare product company, files for $7 million US IPO and sets terms
